Meibomian Gland Dysfunction: The Leading Cause of Dry Eye Disease
What Is Meibomian Gland Dysfunction?
MGD occurs when the small oil-producing glands inside your eyelids become blocked or inflamed, preventing them from releasing the oils your eyes need to stay comfortable. This disruption leads to what is called evaporative dry eye, the most common form of dry eye disease. Understanding how your tear film works helps explain why MGD causes so many different symptoms.
Your eyes are coated in a thin, layered tear film that keeps vision clear and the surface of the eye healthy. Each layer serves a specific purpose.
- The mucin layer is the innermost layer and acts like a primer, helping tears spread evenly across the eye's surface.
- The aqueous layer is the watery middle layer that delivers nutrients, oxygen, and immune protection to the eye.
- The lipid layer is the outermost, oil-based layer produced entirely by the meibomian glands. It seals the surface and slows evaporation.
When the lipid layer is thin or unstable because the meibomian glands are not functioning well, the aqueous layer evaporates too quickly, and dry eye symptoms follow.
Healthy meibomian glands produce a clear, fluid oil called meibum. In MGD, this oil becomes thick and cloudy, similar in consistency to toothpaste. That thickened oil, along with debris and dead cells, clogs the gland openings at the edge of the eyelid. Over time, the glands can shrink and stop producing oil entirely, a process called gland dropout. Early treatment can preserve gland function and, in some cases, help restore it before permanent loss occurs.
Inflammation plays a central and ongoing role in MGD. Blocked glands create conditions where bacteria and Demodex mites (tiny organisms that naturally live on eyelashes) can multiply and contribute to chronic eyelid irritation. This irritation further damages the glands and degrades the quality of their oil, creating a cycle that steadily worsens without treatment.
Recognizing the Symptoms of MGD
MGD produces a wide range of symptoms that are often mistaken for allergies, eye strain, or general irritation. Knowing what to look for can help you seek an accurate diagnosis sooner. Some symptoms may seem unrelated to dryness, which is part of what makes MGD easy to overlook or misidentify.
Patients with MGD frequently report a combination of the following experiences that affect daily comfort and function.
- A sandy or gritty sensation, as if something is caught in the eye
- Burning, stinging, or a persistent feeling of soreness
- Blurry or fluctuating vision that briefly clears after blinking
- Redness along the eyelid edges
- Increased sensitivity to light, also called photophobia
- Difficulty with nighttime driving due to glare or halos around lights
- Eye fatigue during reading or prolonged screen use
- Discomfort or intolerance when wearing contact lenses
This is one of the most confusing aspects of MGD for patients. When the eye surface becomes too dry, the brain responds by triggering a flood of emergency watery tears called reflex tears. These tears are mostly water and contain little to no oil, so they do not lubricate the eye effectively. They tend to overflow and run down the cheek without resolving the underlying dryness, which is why watery eyes and dry eye disease can occur at the same time.
Causes and Risk Factors
MGD rarely has a single cause. It typically develops from a combination of age, lifestyle habits, environmental exposures, and underlying health conditions. Identifying the factors that apply to you helps guide a more targeted and effective treatment plan. Our team evaluates each patient individually rather than applying a one-size-fits-all approach.
Several common aspects of modern life and natural aging directly affect meibomian gland function.
- Age: Gland output naturally declines over time, making MGD significantly more common after age 40.
- Hormonal changes: Shifts in hormone levels, particularly during menopause, can alter the consistency and production of meibum.
- Digital device use: Staring at screens reduces the blink rate considerably. Fewer full blinks mean the glands are squeezed less often, allowing oil to stagnate and harden inside the ducts.
Certain systemic diseases and medications are closely associated with MGD and can significantly worsen its severity.
- Skin conditions such as acne rosacea often affect the eyelid margins in a way that directly impacts meibomian gland health.
- Autoimmune diseases including Sjogren's syndrome, rheumatoid arthritis, and lupus are strongly linked to dry eye and MGD.
- Medications including antihistamines, antidepressants, beta-blockers, diuretics, and retinoid-based acne treatments can reduce oil production or worsen gland function.
If you take any of these medications regularly, it is worth mentioning them during your evaluation so we can consider their potential role in your symptoms.
Everyday habits and surroundings can either protect or stress the meibomian glands over time.
- Living or working in dry, heated, or heavily air-conditioned environments accelerates tear evaporation.
- Contact lens wear can disrupt the tear film and place pressure on the eyelid margin over time.
- Applying eyeliner to the inner rim of the eyelid, sometimes called the waterline, can directly block gland openings.
- Failing to remove eye makeup thoroughly at the end of each day contributes to debris accumulation along the lid margin.
How We Diagnose MGD
Diagnosing MGD involves more than reviewing your symptoms. A comprehensive dry eye evaluation uses specialized technology to directly assess gland structure, oil quality, and tear film stability. This level of detail allows us to understand not just whether you have MGD, but how advanced it is and what is driving it. Our team uses this information to build a personalized treatment plan from the start.
We begin with a validated symptom questionnaire called the Ocular Surface Disease Index (OSDI), which helps us quantify how much your symptoms affect your daily life and establish a baseline for measuring improvement. This is followed by a detailed microscopic exam using a slit lamp, which allows us to closely inspect your eyelid margins, lash roots, and gland openings for signs of inflammation, redness, capping, or blocked ducts.
During the exam, we apply gentle pressure to the eyelid to observe what comes out of the glands. In healthy glands, the expressed oil should be clear and liquid. In MGD, it may appear cloudy, thickened, or may not express at all. This simple technique tells us a great deal about the severity of the blockage and the current state of your gland function.
Meibography uses infrared imaging to take detailed pictures of the meibomian glands through the eyelid. This test is essential for visualizing whether glands have thinned, shortened, or disappeared entirely, a process called gland atrophy or dropout. Seeing the actual structure of your glands helps us understand how much of your condition is reversible and how urgently treatment is needed.
Tear Film Breakup Time (TBUT) measures how quickly your tear film becomes unstable and evaporates after a blink. A rapid breakup time is a hallmark of evaporative dry eye. Tear film osmolarity testing measures the salt concentration in your tears, with higher levels indicating significant instability. When inflammation is suspected, an in-office test called InflammaDry can detect specific inflammatory proteins on the eye's surface, helping to guide decisions about anti-inflammatory treatments.
Treatment: A Stepwise, Personalized Approach
MGD is not curable in the traditional sense, but it is highly manageable with the right combination of treatments. Our approach starts with foundational care and advances to more targeted therapies based on your individual findings. Our team, which includes Dr. Whitney Catanio and Dr. Earle Scharff, each with deep experience in dry eye and ocular surface care, works closely with patients to find the right plan and adjust it over time.
Daily habits form the cornerstone of every MGD management plan. These steps directly support gland function and reduce environmental stress on the eyes.
- Warm compresses: A heated eye mask that maintains a consistent therapeutic temperature for 10 to 15 minutes softens the thickened oil inside the glands so it can flow more freely.
- Eyelid hygiene: Cleaning the eyelid margins daily with a hypochlorous acid spray or a dedicated lid scrub removes bacteria, Demodex, and debris that fuel inflammation.
- Blink exercises: Making a conscious effort to complete full, deliberate blinks during screen use helps express oil from the glands regularly. The 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds) also helps reduce digital eye strain.
- Omega-3 supplementation: A high-quality fish oil or triglyceride-form Omega-3 supplement supports meibum quality and helps reduce inflammatory activity in the glands.
- Environmental adjustments: Using a humidifier, redirecting air vents away from the face, and wearing wraparound sunglasses outdoors all reduce the rate at which tears evaporate.
When at-home care is not sufficient to control inflammation or symptoms, we may incorporate prescription treatments into your plan.
- Corticosteroid eye drops: Used short-term to calm significant flare-ups and reduce eyelid inflammation quickly.
- Immunomodulatory eye drops: Medications such as Restasis, Cequa, and Xiidra work over time to reduce the underlying inflammatory cycle that drives MGD and aqueous deficiency dry eye.
- Antibiotic therapies: Certain antibiotic drops, ointments, or low-dose oral antibiotics such as doxycycline are used primarily for their anti-inflammatory effects on the eyelid margin rather than for treating infection.
For moderate to severe MGD, in-office procedures can provide meaningful and lasting relief by directly targeting the blocked glands in ways that at-home care cannot replicate.
- Thermal pulsation therapy (LipiFlow, TearCare): These devices apply precisely controlled heat to the inner eyelid surface to melt hardened oil, followed by gentle compression to fully clear the gland ducts.
- Intense Pulsed Light (IPL): IPL uses specific wavelengths of light applied to the skin around the eyes. It reduces abnormal blood vessel activity that drives inflammation, and the heat generated helps liquefy the meibum within the glands.
- Lid margin exfoliation (BlephEx): A specialized rotating device precisely cleans the eyelid margin, removing the biofilm, bacteria, and buildup that standard lid wipes cannot fully address.
- Meibomian gland probing: For glands that are physically scarred or obstructed, a sterile, hair-thin probe can clear the duct and restore the pathway for oil flow.
For patients whose dry eye is severe enough to affect contact lens comfort or vision quality, specialty lenses can make a significant difference. Dr. Paul Zerbinopoulos has particular expertise in fitting scleral lenses and moisture-retention lens designs that vault over the cornea and create a fluid reservoir to keep the eye surface continuously hydrated. Dr. Christopher Newton leads our care for patients with dry eye associated with corneal disease, including keratoconus, as well as those managing dry eye following LASIK or preparing for cataract surgery. Our oculoplastic team also collaborates on cases where eyelid structure or positioning is contributing to poor lid closure and worsened gland function.
Frequently Asked Questions
These questions address common points of confusion about MGD that go beyond what is covered above, including how to think about next steps and when to seek care more urgently.
Blepharitis is a broad term for inflammation of the eyelids and has several subtypes with different causes. MGD is a specific form of blepharitis in which meibomian gland obstruction and dysfunction are the primary drivers. Because the two conditions share many symptoms, an accurate diagnosis through gland imaging and oil quality assessment is essential for choosing the right treatment rather than guessing based on symptoms alone.
Yes. A chalazion, which is a firm, painless lump on the eyelid, forms when a meibomian gland becomes completely blocked and inflamed. A stye involves an infected eyelid gland, often near the lash line. Patients with untreated or poorly managed MGD are much more likely to develop these problems repeatedly. Treating the underlying gland dysfunction is the most effective way to reduce how often they occur.
Eye surgery can temporarily disrupt the ocular surface and intensify pre-existing dry eye symptoms. This is especially relevant for MGD, which already compromises the stability of the tear film. Evaluating and treating MGD before surgery is now considered a standard part of pre-operative preparation. This step helps protect the accuracy of pre-surgical measurements and supports a more comfortable recovery. Dr. Christopher Newton works closely with surgical patients on ocular surface optimization before and after procedures.
Gland tissue that has been completely lost cannot be restored. However, many glands that are blocked, inflamed, or producing poor-quality oil can respond well to treatment. Improvement in symptoms, oil quality, and gland output is realistic for many patients when treatment begins early and is followed consistently. This is one reason why regular monitoring with meibography is so valuable, because it allows us to detect worsening before more glands are lost.
For most patients with diagnosed MGD, follow-up visits every 6 to 12 months are appropriate as long as the condition is stable and well-managed. If symptoms flare, new visual changes occur, or a new chalazion develops, we encourage you to schedule sooner rather than waiting for your next routine visit. Recurring or rapidly forming lid lumps in particular deserve prompt evaluation.
Yes, although it is far less common than in adults. Pediatric dry eye, including MGD-related cases, is increasingly recognized, particularly in children with screen-heavy routines, certain skin conditions, or autoimmune disease. Our team has experience evaluating dry eye and ocular surface issues in younger patients, and we approach their care with age-appropriate diagnostics and treatment options.
Expert Dry Eye Care at Rhode Island Eye Institute
MGD is a complex condition, but with the right evaluation and a personalized plan, meaningful relief is within reach for most patients. Our specialists bring decades of combined experience in dry eye diagnosis, meibomian gland therapy, specialty contact lens fitting, and surgical ocular surface care, all under one roof. We invite you to schedule a comprehensive dry eye evaluation and take the first step toward lasting comfort and clearer vision.